INTRACEREBROVENTRICULAR ADMINISTRATION OF SOMATOSTATIN OCTAPEPTIDE COUNTERACTS THE HORMONAL AND METABOLIC RESPONSES TO STRESS IN NORMAL ANDDIABETIC DOGS
Pdg. Miles et al., INTRACEREBROVENTRICULAR ADMINISTRATION OF SOMATOSTATIN OCTAPEPTIDE COUNTERACTS THE HORMONAL AND METABOLIC RESPONSES TO STRESS IN NORMAL ANDDIABETIC DOGS, Metabolism, clinical and experimental, 43(9), 1994, pp. 1134-1143
Intracerebroventricular (ICV) injection of carbachol elicits hormonal
and metabolic responses similar to moderate stress. In normal dogs, IC
V carbachol stimulated marked counterregulatory hormone release, but a
ltered plasma glucose only marginally because the marked increment in
glucose production (R(a)) was almost matched by the increment of utili
zation (R(d)), even though plasma insulin was unchanged. In alloxan-di
abetic dogs, R(d) did not match R(a) and plasma glucose increased subs
tantially. Since somatostatin octapeptide (ODT8-SS) inhibits some symp
athetic mechanisms of the stress response, we explored the extent to w
hich ODT8-SS can alleviate the counterregulatory responses to stress i
nduced by carbachol, and particularly whether it can restore glycemic
control in diabetes. ODT8-SS (20 nmol) was ICV-injected (1) in normal
dogs (n = 5), and (2) prior to ICV carbachol before (n = 7) and after
(n = 6) the induction of alloxan-diabetes. ODT8-SS did not affect basa
l values, but when administered before ICV carbachol there were no sig
nificant increments in plasma epinephrine, cortisol, arginine vasopres
sin (AVP), insulin, glucose, or lactate. There were significant increa
ses in norepinephrine, glucagon, R(a), R(d), and the glucose metabolic
clearance rate (MCR), although they were much smaller than seen previ
ously with ICV carbachol alone. After induction of alloxan-diabetes, R
(d) and MCR did not change with ICV ODT8-SS and carbachol as in normal
dogs, but norepinephrine, epinephrine, glucagon, lactate, plasma gluc
ose, and R(a) increased, although with the exception of glucagon these
increases were much smaller than seen previously with ICV carbachol a
lone. ODT8-SS administered before ICV carbachol in normal or diabetic
animals resulted in increased free fatty acid (FFA) levels. The increa
ses in glycerol were less than and those in FFA greater than seen prev
iously with ICV carbachol alone. Since ODT8-SS does not alter basal co
unterregulatory hormone release but suppresses the release during stre
ss, this is a useful probe to analyze some of the metabolic responses
to stress. When the response to carbachol from our previous report is
compared with the responses to carbachol + ODT8-SS. it is indicated th
at the stress-related increase in R(a) was consistent with stimulation
of the sympathetic nervous system, whereas increased R(d) is related
to an unknown stress-related neuroendocrine mechanism that requires a
permissive effect of insulin. since it was not seen in the frankly dia
betic animals. We hypothesize that the stress-induced increase in R(d)
occurs not only in muscle but also in adipocytes, and that the somato
statin-induced attenuation of R(d) decreased FFA re-esterification and
consequently markedly increased stress-induced FFA release. Although
ODT8-SS substantially decreased the R(a) response in diabetic dogs, th
e hyperglycemic effect of carbachol is only partially attenuated. Thus
, in diabetes moderate stress can disturb glucose homeostasis substant
ially even when the sympathetic nervous system has been markedly suppr
essed. Copyright (C) 1994 by W.B. Saunders Company